Focal Glomerulosclerosis — A Review

  • D. R. Turner
Part of the Developments in Nephrology book series (DINE, volume 3)

Abstract

The precise definition of a disease entity is often very difficult, and all we are doing in glomerulonephritis is dividing it up into a number of what we hope are useful categories. It seems to me that the criticisms which have been levelled at the acceptance of focal glomerulosclerosis as an entity, can equally be used to attack a well-accepted category such as membranous glomerulonephritis. It is suggested that focal sclerosing lesions can be produced by different aetiological factors, but this is also true of membranous glomerulonephritis. It has been pointed out that patients with segmental sclerosing lesions do not always have a uniform prognosis and yet we know that 25% of membranous cases may recover spontaneously. It has also been pointed out that focal sclerosing lesions may complicate other patterns of disease. This also applies to the membranous pattern which can be seen in lupus nephritis and superimposed on mesangio-capillary glomerulonephritis. Finally we now have quite good evidence of recurrence of focal glomerulosclerosis in renal transplants, yet this is rare in membranous glomerulonephritis. On this evidence it would seem that focal glomerulosclerosis is at least as reliable an entity as membranous glomerulonephritis. For the purpose of this account I intend to ignore focal global glomerulosclerosis which several workers have shown to have the same prognosis as minimal change disease.

Keywords

Proteinuria Fibrinogen Nephritis Heroin Glomerulonephritis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Brown CB. Cameron JS. Turner DR. Chantier C. Ogg CS.Google Scholar
  2. Williams DG. and Béwick M. (1978). Focal segmentalGoogle Scholar
  3. glomerulosclerosis with rapid decline in renal function (“malignant FSGS”). Clinical Nephrology Vol. 10 p51–61.Google Scholar
  4. 2.
    Cohen AH. Mampaso F. and Zamboni L. (1977) Glomerular Podocyte Degeneration in Human Renal Disease. Lab. Invest. Vol. 37 P30–42.PubMedGoogle Scholar
  5. 3.
    Futrakul P. Poshyachinda M. and Mitrakul C. (1978). Focal sclerosing glomerulonephritis. A kinetic evaluation of hemostasis and effect of anti-coagulant therapy. Clinical Nephrology. Vol. 10, 180–186.PubMedGoogle Scholar
  6. 4.
    George CRP. Slichter SJM Quadracci LJ. Striker GE. and Harker LA. (1974). Kinetic evaluation of hemostasis in renal disease. N. Eng. J. Med. 291, 1111–1115.CrossRefGoogle Scholar
  7. 5.
    Glasser RJ. Velosa JA. and Michael AF. (1977). Experimental Model of Focal Sclerosis. 1) Relationship to Protein excretion in aminonucleoside nephrosis. Lab. Invest. Vol. 36 p519–526.Google Scholar
  8. 6.
    Schoeneman MJ. Bennett B. and Greifer I (1978). The natural history of focal segmental glomerulosclerosis with and without mesangial hypercellularity in children. Clinical Nephrology Vol. 9 p45–54.Google Scholar
  9. 7.
    Taylor J. Novak R. Christiansen R. and Sorensen ET. (1978) Focal sclerosing glomerulopathy with adverse effects during pregnancy. Arch. Int. Med. Vol. 138 p1695–1696.CrossRefGoogle Scholar
  10. 8.
    White RHR. Yoshikawa N. and Cameron AH. (1980) Prognostic factors in segmental glomerulosclerosis (Abstract) Pediatric Research Vol. 14 p997.CrossRefGoogle Scholar

Copyright information

© Martinus Nijhoff Publishers, The Hague 1981

Authors and Affiliations

  • D. R. Turner

There are no affiliations available

Personalised recommendations